Melrose Industries update not likely to move dial, says UBS

Melrose Industries' upcoming Q3 trading statement in mid-November is not expected to be a significant catalyst for its shares, according to UBS, which maintains a 'Sell' rating and a 410p price target. The company is anticipated to reaffirm 2025 free cash flow guidance, with continued strength in its RRSP portfolio likely offset by ongoing production delays in the A350 program within the Structures division, which is expected to weigh on H2 cash flow and profitability. Investors will look for commentary on future improvements from RRSP growth and reduced working capital demands, but no new 2026 guidance is foreseen.

Analysis

Melrose Industries' upcoming Q3 trading statement is not anticipated to be a significant catalyst, according to a bearish note from UBS which maintains a 'Sell' rating. The company's shares, currently trading at 593p, have been volatile, previously falling from a peak of 700p to below 400p after March guidance for £700 million in adjusted operating profit and at least £100 million in free cash flow disappointed investors, despite a 42% surge in the prior year's profit. UBS expects the upcoming update on November 14th to show continued strength in the Risk and Revenue Sharing Partnerships (RRSP) portfolio, but this positive is likely to be offset by ongoing issues within the Structures division. Specifically, production delays in the A350 program are expected to weigh on cash flow and profitability in the second half. While management will likely reaffirm its 2025 guidance and its long-term goal of £600 million in free cash flow by 2029, the UBS price target has been only marginally increased to 410p from 405p, suggesting significant perceived downside from the current share price.

Key Decisions for Investors

• Investors should note the significant disconnect between the current share price of 593p and UBS's 'Sell' rating with a 410p price target, implying substantial downside risk if the analyst's thesis proves correct.
• Monitor the Q3 update closely for any commentary on the Structures division; confirmation of persistent A350 program-related weakness could validate the bearish outlook on H2 cash flow and profitability.
• Given the expectation of no major positive catalysts, investors might consider whether the current valuation adequately prices in the headwinds within the Structures division against the strength in the RRSP portfolio.
• Pay attention to any forward-looking commentary regarding 2026, as indications of stronger RRSP growth and reduced working capital demands could provide an alternative narrative to the current cautious analyst view.